The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient ...

Panelists discuss how treatment individualization depends on patient-specific factors including age, comorbidities, disease severity, and personal preferences, balancing clinical guidelines with ...

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So, we have made a very big advance ...

Linda Stein Gold, MD, shares insights on new therapeutic options for patients with various psoriasis subtypes and psoriatic arthritis.

Combination immune checkpoint inhibitor therapy (ICI) with ipilimumab (anti–cytotoxic T-lymphocyte–associated protein 4) + nivolumab (anti–PD-1) in untreated, metastatic melanoma has achieved a ...

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

ORLANDO, Fla. — A novel topical therapy for axial hyperhidrosis approved by the FDA in June 2024 is among the increasing number of therapeutic options and new protocols for existing options to improve ...

Michelle and Dan Krueger took their four-month-old daughter, Elly, to a pediatrician the day before Thanksgiving in 2023. Michelle and Dan understood the childhood development phases from their ...

The invitation-only roundtable brought together thought leaders and innovators to discuss the potential of virtual therapies to overcome the stigma and geographic barriers often associated with ...

The Editors of the ASCO Educational Book have authorized correction of the following error that published in the paper by Joshi et al, entitled “Beyond Checkpoint ...